Zynerba Pharmaceuticals Price on March 26, 2024

ZYNEDelisted Stock  USD 0.36  0.01  2.70%   
If you're considering investing in Zynerba Stock, it is important to understand the factors that can impact its price. As of today, the current price of Zynerba Pharmaceuticals stands at 0.36, as last reported on the 24th of November, with the highest price reaching 0.38 and the lowest price hitting 0.36 during the day. We have found twenty-four technical indicators for Zynerba Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check out Zynerba Pharmaceuticals' Market Risk Adjusted Performance of (0.73), mean deviation of 3.36, and Standard Deviation of 4.2 to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Zynerba Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ZYNE
Based on monthly moving average Zynerba Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zynerba Pharmaceuticals by adding Zynerba Pharmaceuticals to a well-diversified portfolio.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

About Zynerba Pharmaceuticals Stock history

Zynerba Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Zynerba is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Zynerba Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Zynerba Pharmaceuticals stock prices may prove useful in developing a viable investing in Zynerba Pharmaceuticals
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania. Zynerba Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 28 people.

Zynerba Pharmaceuticals Stock Technical Analysis

Zynerba Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Zynerba Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Zynerba Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Zynerba Pharmaceuticals Period Price Range

Low
November 24, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Zynerba Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Zynerba Pharmaceuticals November 24, 2024 Market Strength

Market strength indicators help investors to evaluate how Zynerba Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zynerba Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Zynerba Pharmaceuticals stock market strength indicators, traders can identify Zynerba Pharmaceuticals entry and exit signals to maximize returns

Zynerba Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Zynerba Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Zynerba Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Zynerba to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Consideration for investing in Zynerba Stock

If you are still planning to invest in Zynerba Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zynerba Pharmaceuticals' history and understand the potential risks before investing.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum